速递|首周处方破两万张!诺和诺德口服减肥药打响反击战

GLP1减重宝典
Jan 26

整理 | GLP1减重宝典内容团队在礼来加速推进口服GLP-1减肥药之前,Novo Nordisk率先交出了一份超出市场预期的上市答卷。分析师数据显示,诺和诺德最新推出的口服版Wegovy在上市仅两周内即实现快速放量,处方增速不仅显著高于其早期注射剂版本,也在数值层面跑赢了竞争对手的同类产品。这一启动节奏,为公司在减重赛道争夺中赢得了宝贵的时间窗口,也在一定程度上修复了市场对其增长动能的信心。据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10